Clonidine Overdose as an Unusual Cause of Heart Failure

Jagdeep Bhullar1, Arti Patel1, Jaagruthi Chitithoti2

  • 1Kern Medical Center, Bakersfield, CA, USA.

Insights

Clonidine overdose can cause acute heart failure and coronary vasospasm. This case highlights a rare but serious risk associated with this common medication, even in young adults.

Area of Science:

  • Cardiology
  • Pharmacology
  • Neurology

Background:

  • Clonidine, an antihypertensive, lowers blood pressure by reducing sympathetic outflow.
  • It is also used off-label for attention-deficit/hyperactivity disorder (ADHD) due to its central alpha-adrenergic agonism.
  • Understanding clonidine's cardiovascular and neurological effects is crucial for managing overdose.

Observation:

  • A 28-year-old female with hypertension, ADHD, and depression presented with acute heart failure.
  • The patient had ingested a significant overdose of clonidine (30 pills).
  • Significant troponin elevation was noted, indicating cardiac injury.

Findings:

  • The case illustrates a potential diagnosis of clonidine-induced systolic heart failure.
  • Coronary vasospasm is a suspected mechanism secondary to clonidine overdose.
  • This highlights rare but severe cardiovascular complications of clonidine toxicity.

Implications:

  • Clinicians should consider clonidine toxicity in patients with unexplained heart failure and troponemia, especially those with a history of ADHD or hypertension.
  • This case underscores the importance of careful medication management and overdose awareness for clonidine.
  • Further research into the specific mechanisms of clonidine-induced cardiotoxicity may be warranted.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
713
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
479
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
432
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
41
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23